Large pharmaceutical companies have grossly bid up valuations.

There's a large number of acquisitions of companies or mergers [happening], with most generated from [pharmaceutical] companies.

Our goal is not to be just one of the largest pharmaceutical companies, but also to be one of the fastest growing,

I keep encouraging the pharmaceutical companies to put more money into R&D.

The regulatory agenda that's been hanging over pharmaceutical companies has eased up considerably.

These fines and the permanent injunction demonstrate that there is a strong system in place for ensuring that pharmaceutical companies fully comply with all aspects of the drug approval process.